Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Immunology

Abstract #360: A DNA vaccine against Fibroblast Activation Protein acts synergistically with doxorubicin to promote anti-tumor immunity in a mouse model of metastatic breast cancer.

Debbie Liao, Markus Loeffler, Jorg Kruger, Andreas Niethammer, Yungping Luo, Ugur Ozerdem, Tingmei Chen, Rong Xiang and Ralph Reisfeld
Debbie Liao
The Scripps Research Institute, La Jolla, CA; La Jolla Bioengineering Institute, La Jolla, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Loeffler
The Scripps Research Institute, La Jolla, CA; La Jolla Bioengineering Institute, La Jolla, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jorg Kruger
The Scripps Research Institute, La Jolla, CA; La Jolla Bioengineering Institute, La Jolla, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Niethammer
The Scripps Research Institute, La Jolla, CA; La Jolla Bioengineering Institute, La Jolla, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yungping Luo
The Scripps Research Institute, La Jolla, CA; La Jolla Bioengineering Institute, La Jolla, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ugur Ozerdem
The Scripps Research Institute, La Jolla, CA; La Jolla Bioengineering Institute, La Jolla, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tingmei Chen
The Scripps Research Institute, La Jolla, CA; La Jolla Bioengineering Institute, La Jolla, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rong Xiang
The Scripps Research Institute, La Jolla, CA; La Jolla Bioengineering Institute, La Jolla, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ralph Reisfeld
The Scripps Research Institute, La Jolla, CA; La Jolla Bioengineering Institute, La Jolla, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published May 2009
  • Article
  • Info & Metrics
Loading
AACR Annual Meeting-- Apr 18-22, 2009; Denver, CO

Abstract

Tumor associated stroma differs from stroma in normal tissue in that it has an activated phenotype characterized by production of certain extracellular matrix components, growth factors, and cytokines. An activated stroma is associated with increased invasiveness of many epithelial cancers. Cancer associated fibroblasts (CAFs) constitute the major cell type in the tumor stroma and has an activated phenotype often characterized by expression of a transmembrane serine protease known as Fibroblast-activation Protein (FAP). FAP is overexpressed in 90% of CAFs associated with breast carcinomas. We utilized the FAP antigen as a novel target for a DNA vaccine and tested its efficacy in combination with doxorubicin in a mouse model of spontaneous metastatic breast cancer. Oral vaccination with the pFAP vaccine generated a CD8+ T cell dependent anti-tumor response. Additionally, vaccination resulted in a reduction of collagen type I expression in the primary tumors. When combined with chemotherapy, the decrease in collagen expression resulted in an increased uptake of doxorubicin into the primary tumor and increased tumor cell apoptosis resulting in enhanced suppression of tumor growth when compared to vaccination or chemotherapy alone. Using immunofluorescence staining, we show that mice treated with both the FAP-based DNA vaccine and doxorubicin have increased dendritic and CD8 positive cells and decreased macrophages and T regulatory cells in their primary tumors. Additionally, we find that CD8 positive lymphocytes isolated from mice treated with both the vaccine and doxorubicin exhibit enhanced proliferation and activation in response to stimulation with IL-2 or tumor antigen in vitro when compared to control or either treatment alone. These results suggest that targeting of activated fibroblasts within the tumor niche with a vaccine against pFAP in combination with chemotherapy can lead to attenuation of tumor-associated immune suppression resulting in increased anti-tumor immunity.

Citation Information: In: Proc Am Assoc Cancer Res; 2009 Apr 18-22; Denver, CO. Philadelphia (PA): AACR; 2009. Abstract nr 360.

Footnotes

  • 100th AACR Annual Meeting-- Apr 18-22, 2009; Denver, CO

  • American Association for Cancer Research
Back to top
Cancer Research: 69 (9 Supplement)
May 2009
Volume 69, Issue 9 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract #360: A DNA vaccine against Fibroblast Activation Protein acts synergistically with doxorubicin to promote anti-tumor immunity in a mouse model of metastatic breast cancer.
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract #360: A DNA vaccine against Fibroblast Activation Protein acts synergistically with doxorubicin to promote anti-tumor immunity in a mouse model of metastatic breast cancer.
Debbie Liao, Markus Loeffler, Jorg Kruger, Andreas Niethammer, Yungping Luo, Ugur Ozerdem, Tingmei Chen, Rong Xiang and Ralph Reisfeld
Cancer Res May 1 2009 (69) (9 Supplement) 360;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract #360: A DNA vaccine against Fibroblast Activation Protein acts synergistically with doxorubicin to promote anti-tumor immunity in a mouse model of metastatic breast cancer.
Debbie Liao, Markus Loeffler, Jorg Kruger, Andreas Niethammer, Yungping Luo, Ugur Ozerdem, Tingmei Chen, Rong Xiang and Ralph Reisfeld
Cancer Res May 1 2009 (69) (9 Supplement) 360;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Immunology

  • Abstract SY03-03: Modulating innate and adaptive immunity through the manipulation of dendritic cells
  • Abstract SY03-02: Wnt signaling generates “stem-like” self-renewing T cells that can eradicate tumors
  • Abstract SY03-01: The desirable death of the cancer cell: Immunogenic cell death for optimal chemotherapy
Show more 3

Cancer Vaccines: Preclinical and Animal Models -- Poster Presentations - Proffered Abstracts

  • Abstract #371: Induction of an effective anti tumor immunity and tumor regression by irradiated autologous tumor cells expressing GM-CSF and interleukin-18 fusion protein
  • Abstract #355: Anti-CD20 antibody-coated, irradiated autologous tumor cells provide protective immunity against B cell lymphoma in vivo
  • Abstract #366: Evaluation of the antitumor activity of a ganglioside-based vaccine in an N-glycolyl sialic acid-positive mouse melanoma model
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement